Found that on Nov. 13, 2008, the USPTO declared interference between Wyeth's patent No. 7,291,347 for oral dosage of O-desmethylvenlafaxine succinate (Pristiq's active ingredient) and a patent application owned by Sepracor’s. (sorry, no time to dig more, have a plane to catch)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.